- Home
- CSPI vs ALEC Comparison
CSPI vs ALEC Comparison
Compare CSPI & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSPI
- ALEC
- Stock Information
- Founded
- CSPI 1968
- ALEC 2013
- Country
- CSPI United States
- ALEC United States
- Employees
- CSPI N/A
- ALEC N/A
- Industry
- CSPI EDP Services
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CSPI Technology
- ALEC Health Care
- Exchange
- CSPI Nasdaq
- ALEC Nasdaq
- Market Cap
- CSPI 105.9M
- ALEC 124.0M
- IPO Year
- CSPI 1987
- ALEC 2019
- Fundamental
- Price
- CSPI $12.39
- ALEC $2.42
- Analyst Decision
- CSPI
- ALEC Buy
- Analyst Count
- CSPI 0
- ALEC 8
- Target Price
- CSPI N/A
- ALEC $4.50
- AVG Volume (30 Days)
- CSPI 19.9K
- ALEC 1.6M
- Earning Date
- CSPI 08-14-2025
- ALEC 08-07-2025
- Dividend Yield
- CSPI 0.95%
- ALEC N/A
- EPS Growth
- CSPI N/A
- ALEC N/A
- EPS
- CSPI N/A
- ALEC N/A
- Revenue
- CSPI $57,298,000.00
- ALEC $81,130,000.00
- Revenue This Year
- CSPI N/A
- ALEC N/A
- Revenue Next Year
- CSPI N/A
- ALEC $196.86
- P/E Ratio
- CSPI N/A
- ALEC N/A
- Revenue Growth
- CSPI N/A
- ALEC 46.77
- 52 Week Low
- CSPI $9.65
- ALEC $0.87
- 52 Week High
- CSPI $21.95
- ALEC $6.37
- Technical
- Relative Strength Index (RSI)
- CSPI 57.79
- ALEC 62.44
- Support Level
- CSPI $12.33
- ALEC $2.31
- Resistance Level
- CSPI $12.66
- ALEC $2.55
- Average True Range (ATR)
- CSPI 0.83
- ALEC 0.22
- MACD
- CSPI 0.17
- ALEC 0.02
- Stochastic Oscillator
- CSPI 84.57
- ALEC 73.68
About CSPI CSP Inc.
CSP Inc along with its subsidiaries develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments namely Technology Solutions, where the company focus on value-added reseller integrated solutions including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company design, manufacture and deliver products and services to customers that require specialized cyber security services, networking and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates its maximum revenue from the Americas.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.